Pneumococcal Vaccines: Epidemiology Forecast in Asia-Pacific Markets to 2028

2020-04-01
Price :
Published : Apr-2020
No. of Pages : 32
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pneumococcal Vaccines: Executive Summary
2.1 Related Reports
2.2 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.3.1 Pediatric and Elderly Pneumococcal Vaccination Rates
3.3.2 Diagnosed Incidence of Invasive Pneumococcal Disease (Cases per 100,000 Population)
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.4.4 Pneumococcal Vaccination Rates in the Pediatric Population
3.4.5 Pneumococcal Vaccination Rates in the Elderly Population
3.4.6 Diagnosed Incident Cases of Invasive Pneumococcal Disease
3.5 Epidemiological Forecast for Pneumococcal Vaccines and Invasive Pneumococcal Disease (2018-2028)
3.5.1 Pneumococcal Vaccinated Pediatric Population
3.5.2 Pneumococcal Vaccinated Elderly Population
3.5.3 Diagnosed Incident Cases of IPD
3.5.4 Age-Specific Diagnosed Incident Cases of IPD
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of Analysis
3.6.3 Strengths of Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer

List of Tables
Table 1: Risk Factors and Comorbidities for Invasive Pneumococcal Disease
Table 2: Pediatric Pneumococcal Vaccination Rate Trends (%)
Table 3: Elderly Pneumococcal Vaccination Rate Trends (%)

List of Figures
Figure 1: 5GM, Pneumococcal Vaccinated Pediatric Population, Both Sexes, 2018 and 2028
Figure 2: 4GM, Pneumococcal Vaccinated Elderly Population, Both Sexes, 2018 and 2028
Figure 3: 4GM, Diagnosed Incidence of IPD, Both Sexes, All Ages, 2008-2028
Figure 4: India, Diagnosed Incidence of IPD, Both Sexes, All Ages, 2008-2028
Figure 5: 5GM, Sources Used for the Pneumococcal Vaccinated Pediatric Population
Figure 6: 4GM, Sources Used for the Pneumococcal Vaccinated Elderly Population
Figure 7: 5GM, Sources Used for the Diagnosed Incident Cases of IPD
Figure 8: 5GM, Pneumococcal Vaccinated Pediatric Population, Both Sexes, 2018
Figure 9: 4GM, Pneumococcal Vaccinated Elderly Population, Both Sexes, 2018
Figure 10: 5GM, Diagnosed Incident Cases of IPD, Both Sexes, All Ages, 2018
Figure 11: Australia, Japan, and South Korea Age-Specific Diagnosed Incident Cases of IPD, Men and Women, N, 2018
Figure 12: India, Age-Specific Diagnosed Incident Cases of IPD, Men and Women, N, 2018
Figure 13: Urban China, Age-Specific Diagnosed Incident Cases of IPD, Men and Women, N, 2018
Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData